Connecticut 2017 Regular Session

Connecticut Senate Bill SB01039

Introduced
3/16/17  

Caption

An Act Concerning Criminal Liability In The Case Of Drug Overdose Deaths, Increasing The Penalty For The Possession Of A Narcotic And Criminalizing The Misbranding Of Synthetic Drugs.

Impact

One significant change introduced by SB01039 is the heightened penalty for the possession of narcotic substances, reclassifying such possession as a Class D felony. This shift seeks to deter individuals from engaging in the possession or distribution of narcotics. Furthermore, the bill criminalizes the misbranding of synthetic drugs, establishing a Class D felony for individuals who falsify labels on such substances. This aims to protect public health by ensuring clearer communication of risks associated with synthetic drugs that can closely resemble controlled substances.

Summary

SB01039 aims to address the growing issue of drug overdose deaths by establishing criminal liabilities associated with such fatalities. The bill proposes to classify manslaughter as a crime when an individual's actions lead to another's death due to drug overdose from a controlled substance that was improperly manufactured or distributed. This reclassification into a Class B felony reflects a more stringent approach to discourage irresponsible actions that lead to drug-related deaths and aims to hold individuals accountable for their role in distributing illicit substances.

Contention

This bill has not been without controversy. Proponents argue it is an essential measure in combating the opioid epidemic, highlighting the necessity of holding drug distributors accountable. However, opponents express concern about the implications for public health and criminal justice, arguing that increasing penalties may not effectively address the root cause of addiction and may lead to further stigmatization of individuals seeking help. The debate underscores a significant point of contention regarding how best to balance criminal justice reform with public health initiatives in the realm of substance abuse.

Companion Bills

No companion bills found.

Previously Filed As

CT HB05297

An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin.

CT SB00230

An Act Concerning Mailing Of Test Results Related To Operating A Motor Vehicle Or Vessel Under The Influence Of Alcohol Or Drugs.

CT HB05235

An Act Concerning The Department Of Consumer Protection's Recommendations Regarding Cannabis Regulation.

CT SB00133

An Act Concerning Regulation Of Prescription Drugs And Related Professions.

CT HB05500

An Act Concerning Revisions To Various Laws Concerning Ignition Interlock Devices, The Department Of Correction, Judicial Retirement Salaries And Criminal Law And Criminal Procedure.

CT HB05150

An Act Concerning Cannabis And Hemp Regulation.

CT SB00445

An Act Concerning A Jobs Program For Youth Impacted By The Juvenile Justice System, Review Of Probation Violations And State-wide Expansion Of Truancy Clinics.

CT SB00008

An Act Concerning Drug Affordability.

CT HB05450

An Act Concerning Artificial Intelligence, Deceptive Synthetic Media And Elections.

CT HB05397

An Act Concerning Emergency Intervention By A Police Officer When A Person Is Incapacitated By Drugs Or Due To A Medical Emergency.

Similar Bills

CT HB05553

An Act Concerning Criminal Liability In The Case Of Drug Overdose Deaths, Increasing The Penalty For The Possession Of A Narcotic And Criminalizing The Misbranding Of Synthetic Drugs.

HI SB807

Relating To Cannabis.

HI HB734

Relating To Cannabis.

HI SB807

Relating To Cannabis.

HI HB734

Relating To Cannabis.

NJ S166

Allows certain drug dealing offenses to be graded by "units," rather than weight, of controlled dangerous substances.

CA AB1753

Controlled substances: CURES database.

NJ A5649

Enhances penalties for distribution and manufacture of certain amounts of fentanyl.